Several studies showed that increased expression of Sema3C is a poor prognostic factor for patients with breast cancer (18), glioblastoma (19), or gastric cancer (7), implying that Sema3C may be involved in cancer progression possibly through the stimulation of angiogenesis (7,18). The gene discussed is SEMA3C; the disease is glioblastoma.